According to Aurobindo Pharma 's latest financial reports the company's current EPS (TTM) is 0,59ย โฌ. In 2018 the company made an earnings per share (EPS) of 0,49ย โฌ a decrease over its 2017 EPS that were of 0,55ย โฌ.